BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25681012)

  • 1. Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation.
    Kievit FM; Stephen ZR; Wang K; Dayringer CJ; Sham JG; Ellenbogen RG; Silber JR; Zhang M
    Mol Oncol; 2015 Jun; 9(6):1071-80. PubMed ID: 25681012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation using gold nanoparticles.
    Liu Z; Yan H; Li H
    Environ Toxicol Pharmacol; 2017 Jul; 53():40-45. PubMed ID: 28501783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma.
    Kievit FM; Wang K; Ozawa T; Tarudji AW; Silber JR; Holland EC; Ellenbogen RG; Zhang M
    Nanomedicine; 2017 Oct; 13(7):2131-2139. PubMed ID: 28614736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
    Montaldi AP; Godoy PR; Sakamoto-Hojo ET
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone chaperone FACT complex inhibitor CBL0137 interferes with DNA damage repair and enhances sensitivity of medulloblastoma to chemotherapy and radiation.
    Song H; Xi S; Chen Y; Pramanik S; Zeng J; Roychoudhury S; Harris H; Akbar A; Elhag SS; Coulter DW; Ray S; Bhakat KK
    Cancer Lett; 2021 Nov; 520():201-212. PubMed ID: 34271103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
    Luo M; Kelley MR
    Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1/Ref-1.
    Naidu MD; Mason JM; Pica RV; Fung H; Peña LA
    J Radiat Res; 2010; 51(4):393-404. PubMed ID: 20679741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles of Ape1 protein in the repair of DNA damage induced by ionizing radiation or bleomycin.
    Fung H; Demple B
    J Biol Chem; 2011 Feb; 286(7):4968-77. PubMed ID: 21081487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
    Laev SS; Salakhutdinov NF; Lavrik OI
    Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apurinic/apyrimidinic endonuclease is inversely associated with response to radiotherapy in pediatric ependymoma.
    Bobola MS; Jankowski PP; Gross ME; Schwartz J; Finn LS; Blank A; Ellenbogen RG; Silber JR
    Int J Cancer; 2011 Nov; 129(10):2370-9. PubMed ID: 21207372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo.
    Xiang DB; Chen ZT; Wang D; Li MX; Xie JY; Zhang YS; Qing Y; Li ZP; Xie J
    Cancer Gene Ther; 2008 Oct; 15(10):625-35. PubMed ID: 18535621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
    Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
    Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
    Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR
    Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of APE1 enhances sensitivity of human hepatocellular carcinoma cells to radiotherapy in vitro and in a xenograft model.
    Cun Y; Dai N; Xiong C; Li M; Sui J; Qian C; Li Z; Wang D
    PLoS One; 2013; 8(2):e55313. PubMed ID: 23418439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcoma.
    Jiang X; Shan J; Dai N; Zhong Z; Qing Y; Yang Y; Zhang S; Li C; Sui J; Ren T; Li M; Wang D
    Cancer Sci; 2015 Oct; 106(10):1394-401. PubMed ID: 26250694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Ape1 and base excision repair in the radioresponse and heat-radiosensitization of HeLa Cells.
    Batuello CN; Kelley MR; Dynlacht JR
    Anticancer Res; 2009 Apr; 29(4):1319-25. PubMed ID: 19414382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
    Fishel ML; Kelley MR
    Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apurinic/apyrimidinic endonuclease 1 (APE1) contributes to resveratrol‑induced neuroprotection against oxygen‑glucose deprivation and re‑oxygenation injury in HT22 cells: Involvement in reducing oxidative DNA damage.
    Jia JY; Tan ZG; Liu M; Jiang YG
    Mol Med Rep; 2017 Dec; 16(6):9786-9794. PubMed ID: 29039534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition.
    Wang D; Luo M; Kelley MR
    Mol Cancer Ther; 2004 Jun; 3(6):679-86. PubMed ID: 15210853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.